| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0061 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |